Teva to acquire Allergan Generics for $40.5 billion
MLex Summary: Teva Pharmaceutical Industries has agreed to acquire the generics unit of global pharmaceutical company Allergan for $40.5 billion. Both companies are listed on the New York Stock Exchange. The...To view the full article, register now.
Already a subscriber? Click here to view full article